Papillomavirus truncated L1 protein and fusion protein constructs

US6649167B2 · kind B2 · utility

Assignee

• Medi&Gene Inc. · DE

Inventors

• Michael Hallek · Cologne, DE
• Alexander Burger · Munich, DE

Key dates

• Filing date: Apr 3, 2001
• Grant date: Nov 18, 2003
• Expiry date: Apr 3, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S977/802
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.